Taylor S. Howard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Taylor S. Howard has a total of 147 co-authors. Here are the top co-authors by number of shared publications:
Christina Y. Miyake
6 shared publicationsSantiago O. Valdes
6 shared publicationsJeffrey J. Kim
Department of Pediatrics, Lillie Frank Abercrombie Section of Pediatric Cardiology, Texas Children's Hospital Baylor College of Medicine Houston Texas USA
5 shared publicationsTam Dan N. Pham
Division of Cardiology, Department of Pediatrics, Texas Children’s Hospital and Baylor College of Medicine, Houston (C.Y.M., S.B.S.,T.S.H., S.O.V., T.D.N.P., J.J.K.).
3 shared publications- Andrew P. Landstrom
Department of Pediatrics, Division of Cardiology, Children’s Hospital of Philadelphia, Philadelphia & Perelman School of Medicine, University of Pennsylvania, Philadelphia (B.B., A.P.L.).
2 shared publications - Chet R. Villa
Cincinnati Children's Hospital Medical Center University of Cincinnati College of Medicine Cincinnati USA
2 shared publications
Latest Publications
- 26 January 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (4) , 695-704
Bundle Branch Area Pacing in Patients With Moderate to Complex Biventricular Congenital Heart Disease
Introduction: Pacing‐induced cardiomyopathy in patients with congenital heart disease (CHD) is a cause of significant morbidity. Reports of bundle branch area pacing (BBAP) in this population remain limited. Methods and Results: Eighteen patients with moderate to complex biventricular CHD, as defined by the Bethesda criteria, underwent BBAP attempt with success in 15 (83%). The median age at implant was 17 years (IQR 13, 40). Among the patients with successful BBAP, the median QRSd was 128 ms (IQR 120, 132), and the median V6‐RWPT was 72 ms (IQR 58, 80). In the subgroup of patients who underwent successful BBAP for improved synchrony, there was a significant reduction in the QRSd (167 ms [IQR 147 186] vs. 132 ms [IQR 127 135]; p = 0.01). Electrical parameters remained stable over 4–6 months of follow‐up apart from threshold, which had a statistically significant but clinically irrelevant rise; this was followed by stabilization (threshold at last follow‐up was 0.75 V at 0.4 ms [IQR 0.7 V, 1 V]). Before‐ and after‐pacing ejection fraction (EF) was unchanged in systemic left ventricle (LV) group (LVEF 58% [IQR 48%, 62%] vs. 60% [IQR 54%, 64%]; p = 0.44). There was a non‐statistically significant trend towards improvement in the systemic right ventricle (RV) group (RV fractional area change 26.1% [IQR 20.9%, 28.5%] vs. 30.2% [IQR 24.6%, 32.8%]; p = 0.07). Conclusions: The use of BBAP in patients with moderate to complex biventricular CHD appears to be safe and feasible. The modality delivers good electrical synchrony with lead parameters remaining within normal limits.
- 26 January 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (4) , 695-704
Bundle Branch Area Pacing in Patients With Moderate to Complex Biventricular Congenital Heart Disease
Introduction: Pacing‐induced cardiomyopathy in patients with congenital heart disease (CHD) is a cause of significant morbidity. Reports of bundle branch area pacing (BBAP) in this population remain limited. Methods and Results: Eighteen patients with moderate to complex biventricular CHD, as defined by the Bethesda criteria, underwent BBAP attempt with success in 15 (83%). The median age at implant was 17 years (IQR 13, 40). Among the patients with successful BBAP, the median QRSd was 128 ms (IQR 120, 132), and the median V6‐RWPT was 72 ms (IQR 58, 80). In the subgroup of patients who underwent successful BBAP for improved synchrony, there was a significant reduction in the QRSd (167 ms [IQR 147 186] vs. 132 ms [IQR 127 135]; p = 0.01). Electrical parameters remained stable over 4–6 months of follow‐up apart from threshold, which had a statistically significant but clinically irrelevant rise; this was followed by stabilization (threshold at last follow‐up was 0.75 V at 0.4 ms [IQR 0.7 V, 1 V]). Before‐ and after‐pacing ejection fraction (EF) was unchanged in systemic left ventricle (LV) group (LVEF 58% [IQR 48%, 62%] vs. 60% [IQR 54%, 64%]; p = 0.44). There was a non‐statistically significant trend towards improvement in the systemic right ventricle (RV) group (RV fractional area change 26.1% [IQR 20.9%, 28.5%] vs. 30.2% [IQR 24.6%, 32.8%]; p = 0.07). Conclusions: The use of BBAP in patients with moderate to complex biventricular CHD appears to be safe and feasible. The modality delivers good electrical synchrony with lead parameters remaining within normal limits.
- 1 October 2025
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 18 (10) , e013437
Intellectual and Neurodevelopmental Delays in Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: Distinct Characteristics and a More Malignant Neurocardiac Phenotype
BACKGROUND: Marked intellectual and neurodevelopmental delay (INDD) was noted in 6 unrelated patients diagnosed with RYR2 -related catecholaminergic polymorphic ventricular tachycardia (CPVT) from a single center. Patients exhibited similar distinct phenotypic features not previously described. We aimed to determine the prevalence of INDD in CPVT, compare clinical characteristics between patients with CPVT with and without INDD, and investigate the possibility of a unique neurocardiac CPVT phenotype. METHODS: Retrospective combined review of patients with RYR2 -related CPVT diagnosed ≤18 years with and without INDD from a single center and the International Pediatric CPVT Registry. Patients with hypoxic ischemic insult were excluded unless INDD preceded injury. RESULTS: Among a total of 168 patients, INDD was reported in 19 (11.3% [95% CI, 7.0%–17.1%]). When compared with cases without INDD, patients with INDD exhibited distinct features including (1) younger age at onset of symptoms (median 7.0 versus 10.0 years; P =0.04); (2) higher frequency of atrial tachyarrhythmias (84.2% versus 16.3%, P P P =0.001 respectively); (4) cardiac structural changes or systolic dysfunction (36.8% versus 1.3%, P P =0.001). INDD-related RYR2 genetic variants clustered within the central and channel domains and may be specific to certain variants. CONCLUSIONS: This study demonstrates a wider spectrum of RYR2 -related disease, with a subset associated with extracardiac manifestations. Certain RYR2 variants may lead to a neurocardiac phenotype with distinct features that are important to recognize, as these patients may be at higher risk.
- 1 October 2025
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 18 (10) , e013437
Intellectual and Neurodevelopmental Delays in Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: Distinct Characteristics and a More Malignant Neurocardiac Phenotype
BACKGROUND: Marked intellectual and neurodevelopmental delay (INDD) was noted in 6 unrelated patients diagnosed with RYR2 -related catecholaminergic polymorphic ventricular tachycardia (CPVT) from a single center. Patients exhibited similar distinct phenotypic features not previously described. We aimed to determine the prevalence of INDD in CPVT, compare clinical characteristics between patients with CPVT with and without INDD, and investigate the possibility of a unique neurocardiac CPVT phenotype. METHODS: Retrospective combined review of patients with RYR2 -related CPVT diagnosed ≤18 years with and without INDD from a single center and the International Pediatric CPVT Registry. Patients with hypoxic ischemic insult were excluded unless INDD preceded injury. RESULTS: Among a total of 168 patients, INDD was reported in 19 (11.3% [95% CI, 7.0%–17.1%]). When compared with cases without INDD, patients with INDD exhibited distinct features including (1) younger age at onset of symptoms (median 7.0 versus 10.0 years; P =0.04); (2) higher frequency of atrial tachyarrhythmias (84.2% versus 16.3%, P P P =0.001 respectively); (4) cardiac structural changes or systolic dysfunction (36.8% versus 1.3%, P P =0.001). INDD-related RYR2 genetic variants clustered within the central and channel domains and may be specific to certain variants. CONCLUSIONS: This study demonstrates a wider spectrum of RYR2 -related disease, with a subset associated with extracardiac manifestations. Certain RYR2 variants may lead to a neurocardiac phenotype with distinct features that are important to recognize, as these patients may be at higher risk.
- 21 February 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (1) , 462-466
Leadless Pacemaker Implantation in an Adolescent with Durable LVAD Support
Left ventricular assist device (LVAD) utilization is increasing in pediatrics. These patients are often complex and may require treatment of AV block. Leadless pacing has been associated with a lower risk of device-related adverse events, but there are no reports of a leadless pacemaker implant in a pediatric patient with LVAD support. This report describes the use of a leadless pacemaker implantation in a 17-year-old patient with dilated cardiomyopathy and continuous flow LVAD support which facilitated transition to outpatient care.
- 21 February 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (1) , 462-466
Leadless Pacemaker Implantation in an Adolescent with Durable LVAD Support
Left ventricular assist device (LVAD) utilization is increasing in pediatrics. These patients are often complex and may require treatment of AV block. Leadless pacing has been associated with a lower risk of device-related adverse events, but there are no reports of a leadless pacemaker implant in a pediatric patient with LVAD support. This report describes the use of a leadless pacemaker implantation in a 17-year-old patient with dilated cardiomyopathy and continuous flow LVAD support which facilitated transition to outpatient care.
- 1 November 2024
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 17 (11) , e013114
Desmoplakin Cardiomyopathy in Pediatric Patients: A Distinct, Underrecognized Cohort of Arrhythmogenic Cardiomyopathy
BACKGROUND: DSP cardiomyopathy is a distinct subset of arrhythmogenic cardiomyopathy, reported primarily in adults, that has predominantly left ventricular involvement and features of myocarditis. Clinical characteristics, risk stratification, and management of pediatric patients with DSP variants are not well known. We sought to identify phenotypic features and prognosis of pediatric patients with DSP pathogenic or likely pathogenic variants. METHODS: Multicenter, retrospective study of patients DSP variants from 6 tertiary pediatric hospitals. RESULTS: Thirty-four patients, including 10 probands with clinical disease and 24 genotype-positive phenotype-negative patients, were included in the study. The majority of probands were initially diagnosed with myocarditis (50%) and had biventricular (60%) or left ventricular predominant (40%) disease. Chest pain was the most common symptom at presentation (30%), and all had troponin elevation. Probands with homozygous or compound heterozygous DSP variants were likely to present at an early age (DSP cardiomyopathy in children and adolescents has varied phenotypic manifestations based on age and genotype and often can be diagnosed as myocarditis. Severe left ventricular dysfunction and biventricular involvement may be associated with a higher likelihood of malignant ventricular tachyarrhythmia.
- 1 November 2024
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 17 (11) , e013114
Desmoplakin Cardiomyopathy in Pediatric Patients: A Distinct, Underrecognized Cohort of Arrhythmogenic Cardiomyopathy
BACKGROUND: DSP cardiomyopathy is a distinct subset of arrhythmogenic cardiomyopathy, reported primarily in adults, that has predominantly left ventricular involvement and features of myocarditis. Clinical characteristics, risk stratification, and management of pediatric patients with DSP variants are not well known. We sought to identify phenotypic features and prognosis of pediatric patients with DSP pathogenic or likely pathogenic variants. METHODS: Multicenter, retrospective study of patients DSP variants from 6 tertiary pediatric hospitals. RESULTS: Thirty-four patients, including 10 probands with clinical disease and 24 genotype-positive phenotype-negative patients, were included in the study. The majority of probands were initially diagnosed with myocarditis (50%) and had biventricular (60%) or left ventricular predominant (40%) disease. Chest pain was the most common symptom at presentation (30%), and all had troponin elevation. Probands with homozygous or compound heterozygous DSP variants were likely to present at an early age (DSP cardiomyopathy in children and adolescents has varied phenotypic manifestations based on age and genotype and often can be diagnosed as myocarditis. Severe left ventricular dysfunction and biventricular involvement may be associated with a higher likelihood of malignant ventricular tachyarrhythmia.
- 26 July 2023
- Published by Elsevier in Cardiac Electrophysiology Clinics
- Vol. 15 (4) , 515-525
Translation of Tools and Techniques from the Adult Electrophysiology World to Pediatric Cardiac Implantable Electronic Devices
- 26 July 2023
- Published by Elsevier in Cardiac Electrophysiology Clinics
- Vol. 15 (4) , 515-525
Translation of Tools and Techniques from the Adult Electrophysiology World to Pediatric Cardiac Implantable Electronic Devices
- 1 April 2023
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 16 (4) , e011447
Transcatheter Leadless Pacing in Children: A PACES Collaborative Study in the Real-World Setting
Background: Transcatheter Leadless Pacemakers (TLP) are a safe and effective option for adults with pacing indications. These devices may be an alternative in pediatric patients and patients with congenital heart disease for whom repeated sternotomies, thoracotomies, or transvenous systems are unfavorable. However, exemption of children from clinical trials has created uncertainty over the indications, efficacy, and safety of TLP in the pediatric population. The objectives of this study are to evaluate clinical indications, procedural characteristics, electrical performance, and outcomes of TLP implantation in children. Methods: Retrospective data were collected from patients enrolled in the Pediatric and Congenital Electrophysiology Society TLP registry involving 15 centers. Patients ≤21 years of age who underwent Micra (Medtronic Inc, Minneapolis, MN) TLP implantation and had follow-up of ≥1 week were included in the study. Results: The device was successfully implanted in 62 of 63 registry patients (98%) at a mean age of 15±4.1 years and included 20 (32%) patients with congenital heart disease. The mean body weight at TLP implantation was 55±19 kg and included 8 patients ≤8 years of age and ≤30 kg in weight. TLP was implanted by femoral (n=55, 87%) and internal jugular (n=8, 12.6%) venous approaches. During a mean follow-up period of 9.5±5.3 months, there were 10 (16%) complications including one cardiac perforation/pericardial effusion, one nonocclusive femoral venous thrombus, and one retrieval and replacement of TLP due to high thresholds. There were no deaths, TLP infections, or device embolizations. Electrical parameters, including capture thresholds, R wave sensing, and pacing impedances, remained stable. Conclusions: Initial results from the Pediatric and Congenital Electrophysiology Society TLP registry demonstrated a high level of successful Micra device implants via femoral and internal venous jugular approaches with stable electrical parameters and infrequent major complications. Long-term prospective data are needed to confirm the reproducibility of these initial findings.
- 1 April 2023
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 16 (4) , e011447
Transcatheter Leadless Pacing in Children: A PACES Collaborative Study in the Real-World Setting
Background: Transcatheter Leadless Pacemakers (TLP) are a safe and effective option for adults with pacing indications. These devices may be an alternative in pediatric patients and patients with congenital heart disease for whom repeated sternotomies, thoracotomies, or transvenous systems are unfavorable. However, exemption of children from clinical trials has created uncertainty over the indications, efficacy, and safety of TLP in the pediatric population. The objectives of this study are to evaluate clinical indications, procedural characteristics, electrical performance, and outcomes of TLP implantation in children. Methods: Retrospective data were collected from patients enrolled in the Pediatric and Congenital Electrophysiology Society TLP registry involving 15 centers. Patients ≤21 years of age who underwent Micra (Medtronic Inc, Minneapolis, MN) TLP implantation and had follow-up of ≥1 week were included in the study. Results: The device was successfully implanted in 62 of 63 registry patients (98%) at a mean age of 15±4.1 years and included 20 (32%) patients with congenital heart disease. The mean body weight at TLP implantation was 55±19 kg and included 8 patients ≤8 years of age and ≤30 kg in weight. TLP was implanted by femoral (n=55, 87%) and internal jugular (n=8, 12.6%) venous approaches. During a mean follow-up period of 9.5±5.3 months, there were 10 (16%) complications including one cardiac perforation/pericardial effusion, one nonocclusive femoral venous thrombus, and one retrieval and replacement of TLP due to high thresholds. There were no deaths, TLP infections, or device embolizations. Electrical parameters, including capture thresholds, R wave sensing, and pacing impedances, remained stable. Conclusions: Initial results from the Pediatric and Congenital Electrophysiology Society TLP registry demonstrated a high level of successful Micra device implants via femoral and internal venous jugular approaches with stable electrical parameters and infrequent major complications. Long-term prospective data are needed to confirm the reproducibility of these initial findings.
- Open Access
- 28 February 2023
- Published by Wolters Kluwer Health in Circulation
- Vol. 147 (9) , 718-727
The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy
Background: Hypertrophic cardiomyopathy (HCM) can be associated with an abnormal exercise response. In adults with HCM, abnormal results on exercise stress testing are predictive of heart failure outcomes. Our goal was to determine whether an abnormal exercise response is associated with adverse outcomes in pediatric patients with HCM. Methods: In an international cohort study including 20 centers, phenotype-positive patients with primary HCM who were z scores, higher resting left ventricular outflow tract gradient, and higher frequency of myectomy compared with participants with normal test results ( P P =0.005). Patients with exercise-induced ischemia were most likely to experience all-cause death or transplant (hazard ratio, 4.86 [95% CI, 1.69–13.99]), followed by those with an abnormal blood pressure response (hazard ratio, 3.19 [95% CI, 1.32–7.71]). Exercise-induced ischemia was also independently associated with lower SCD event-free survival (hazard ratio, 3.32 [95% CI, 1.27–8.70]). Exercise-induced ectopy was not associated with survival. Conclusions: Exercise abnormalities are common in childhood HCM. An abnormal exercise test result was independently associated with lower transplant-free survival, especially in those with an ischemic or abnormal blood pressure response with exercise. Exercise-induced ischemia was also independently associated with SCD events. These findings argue for routine exercise testing in childhood HCM as part of ongoing risk assessment.
- 28 February 2023
- Published by Wolters Kluwer Health in Circulation
- Vol. 147 (9) , 718-727
Open AccessThe Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy
Background: Hypertrophic cardiomyopathy (HCM) can be associated with an abnormal exercise response. In adults with HCM, abnormal results on exercise stress testing are predictive of heart failure outcomes. Our goal was to determine whether an abnormal exercise response is associated with adverse outcomes in pediatric patients with HCM. Methods: In an international cohort study including 20 centers, phenotype-positive patients with primary HCM who were z scores, higher resting left ventricular outflow tract gradient, and higher frequency of myectomy compared with participants with normal test results ( P P =0.005). Patients with exercise-induced ischemia were most likely to experience all-cause death or transplant (hazard ratio, 4.86 [95% CI, 1.69–13.99]), followed by those with an abnormal blood pressure response (hazard ratio, 3.19 [95% CI, 1.32–7.71]). Exercise-induced ischemia was also independently associated with lower SCD event-free survival (hazard ratio, 3.32 [95% CI, 1.27–8.70]). Exercise-induced ectopy was not associated with survival. Conclusions: Exercise abnormalities are common in childhood HCM. An abnormal exercise test result was independently associated with lower transplant-free survival, especially in those with an ischemic or abnormal blood pressure response with exercise. Exercise-induced ischemia was also independently associated with SCD events. These findings argue for routine exercise testing in childhood HCM as part of ongoing risk assessment.
- 31 October 2022
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (1) , e14410
Atrial tachyarrhythmias after lung transplantation in children: A common occurrence
Background: Atrial arrhythmia's (AA) following lung transplant in adults are a well‐described clinical finding. In pediatrics, however, there are limited data with some reports suggesting that arrhythmias are rare.Methods: We performed a single‐center retrospective review of lung transplant recipients from January 2013 to June 2020. A detailed evaluation of clinical characteristics, presence of arrhythmias, and outcomes was completed. Arrhythmias were documented based on inpatient telemetry or remote Holter monitoring. Analyses assessing risk factors for arrhythmias and associations with clinical outcomes were performed.Results: Ninety‐one lung transplants were performed in 90 patients. Post‐operative AA occurred following 19% transplants. Ectopic atrial tachycardia was seen in 14%, atrial flutter in 2%, and a combination in 2%. The majority of these arrhythmias occurred within the first 45 days post‐operatively. Antiarrhythmic treatment was required in 59%, but none required ablation or electrical cardioversion. In patients followed for a year or more, 88% had resolution of their arrhythmia. Arrhythmias were not associated with mortality. In further analysis, however, the presence of arrhythmia was associated with an increased length of ICU stay (median of 12 days (IQR 6, 23) versus 5 days (IQR 4, 9); p = .019) and overall length of hospital stay (median of 26 days (IQR 19, 36) versus 17 days (IQR 19, 36); p = .043).Conclusions: Atrial tachyarrhythmias after lung transplantation are common in the pediatric population and usually occur early. Although they frequently require medical therapy and are associated with longer stays, there is no associated increased mortality. In addition, the arrhythmias typically self‐resolve.
- 31 October 2022
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (1) , e14410
Atrial tachyarrhythmias after lung transplantation in children: A common occurrence
Background: Atrial arrhythmia's (AA) following lung transplant in adults are a well‐described clinical finding. In pediatrics, however, there are limited data with some reports suggesting that arrhythmias are rare.Methods: We performed a single‐center retrospective review of lung transplant recipients from January 2013 to June 2020. A detailed evaluation of clinical characteristics, presence of arrhythmias, and outcomes was completed. Arrhythmias were documented based on inpatient telemetry or remote Holter monitoring. Analyses assessing risk factors for arrhythmias and associations with clinical outcomes were performed.Results: Ninety‐one lung transplants were performed in 90 patients. Post‐operative AA occurred following 19% transplants. Ectopic atrial tachycardia was seen in 14%, atrial flutter in 2%, and a combination in 2%. The majority of these arrhythmias occurred within the first 45 days post‐operatively. Antiarrhythmic treatment was required in 59%, but none required ablation or electrical cardioversion. In patients followed for a year or more, 88% had resolution of their arrhythmia. Arrhythmias were not associated with mortality. In further analysis, however, the presence of arrhythmia was associated with an increased length of ICU stay (median of 12 days (IQR 6, 23) versus 5 days (IQR 4, 9); p = .019) and overall length of hospital stay (median of 26 days (IQR 19, 36) versus 17 days (IQR 19, 36); p = .043).Conclusions: Atrial tachyarrhythmias after lung transplantation are common in the pediatric population and usually occur early. Although they frequently require medical therapy and are associated with longer stays, there is no associated increased mortality. In addition, the arrhythmias typically self‐resolve.
- 26 October 2022
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 9 (1) , 57-69
Atrial Standstill in the Pediatric Population
- 26 October 2022
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 9 (1) , 57-69
Atrial Standstill in the Pediatric Population